Bioline Rx reported $3.36M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Bio Path USD 0 0 Mar/2025
Bioline Rx USD 3.36M 2.08M Mar/2026
Capricor Therapeutics USD 3.38M 0 Mar/2025